0.019440 0.000000 0.000000 0.000000 0.017015 0.000000 0.000000 0.000000 0.016205 0.00000 0.00000 0.00000 Tyndall, J.D. Reid, R.C. Tyssen, D.P. Jardine, D.K. Todd, B. Passmore, M. March, D.R. Pattenden, L.K. Alewood, D. Hu, S.H. Alewood, P.F. Birch, C.J. Martin, J.L. Fairlie, D.P. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 8 90.00 90.00 90.00 51.440 58.770 61.710 C4 H9 N O2 103.120 n ALPHA-AMINOBUTYRIC ACID L-peptide linking C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking H2 O 18.015 WATER non-polymer C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C32 H48 N4 O6 S 616.812 (10S,13S,1'R)-13-[1'-HYDROXY-2'-(N-P-AMINOBENZENESULFONYL-1''-AMINO-3''-METHYLBUTYL)ETHYL]-8,11-DIOXO-10-ISOPROPYL-2-OXA-9,12-DIAZABICYCLO [13.2.2]NONADECA-15,17,18-TRIENE non-polymer C5 H9 N O2 115.130 y PROLINE L-peptide linking O4 S -2 96.063 SULFATE ION non-polymer C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking US J.Med.Chem. JMCMAR 0151 0022-2623 43 3495 3504 10.1021/jm000013n 11000004 Synthesis, stability, antiviral activity, and protease-bound structures of substrate-mimicking constrained macrocyclic inhibitors of HIV-1 protease. 2000 US Biochemistry BICHAW 0033 0006-2960 38 7978 7988 10.1021/bi990174x Molecular Recognition of Macrocyclic Peptidomimetic Inhibitors by HIV-1 Protease. 1999 US J.Am.Chem.Soc. JACSAT 0004 0002-7863 118 3375 3379 10.1021/ja953790z Substrate Based Cyclic Peptidomimetics Of Phe Ile Val That Inhibit HIV-1 Protease Using a Novel Enzyme Binding Mode. 1996 US J.Am.Chem.Soc. JACSAT 0004 0002-7863 117 10220 10226 Regioselective Structural and Functional Mimicry Of Peptides: Design Of Hydrolytically Stable Cyclic Peptidomimetic Inhibitors Of HIV-1 Protease. 1995 10.2210/pdb1d4l/pdb pdb_00001d4l 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 298.0 1 IMAGE PLATE 1998-05-08 RIGAKU RAXIS IIC SINGLE WAVELENGTH M x-ray 1 1.54 1.0 1.54 ROTATING ANODE RIGAKU RU200 10765.687 HIV-1 PROTEASE 3.4.23.16 Q7K, L33I, C67(ABA), C95(ABA) 2 syn polymer 96.063 SULFATE ION 3 syn non-polymer 616.812 (10S,13S,1'R)-13-[1'-HYDROXY-2'-(N-P-AMINOBENZENESULFONYL-1''-AMINO-3''-METHYLBUTYL)ETHYL]-8,11-DIOXO-10-ISOPROPYL-2-OXA-9,12-DIAZABICYCLO [13.2.2]NONADECA-15,17,18-TRIENE 1 syn non-polymer 18.015 water 121 nat water no yes PQITLWKRPLVTIRIGGQLKEALLDTGADDTVIEEMNLPGKWKPKMIGGIGGFIKVRQYDQIPVEI(ABA)GHKAIGTVL VGPTPVNIIGRNLLTQIG(ABA)TLNF PQITLWKRPLVTIRIGGQLKEALLDTGADDTVIEEMNLPGKWKPKMIGGIGGFIKVRQYDQIPVEIAGHKAIGTVLVGPT PVNIIGRNLLTQIGATLNF A,B polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n 1 2.16 43.18 VAPOR DIFFUSION, HANGING DROP 5.5 ammonium sulfate. acetate buffer, , pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 293.0K 293.0 software database_2 struct_conn struct_ref_seq_dif struct_site repository Initial release Version format compliance Version format compliance Refinement description Database references Derived calculations 1 0 2000-10-11 1 1 2008-04-27 1 2 2011-07-13 1 3 2017-10-04 1 4 2021-11-03 _database_2.pdbx_DOI _database_2.pdbx_database_accession _struct_conn.pdbx_leaving_atom_flag _struct_ref_seq_dif.details _struct_site.pdbx_auth_asym_id _struct_site.pdbx_auth_comp_id _struct_site.pdbx_auth_seq_id 1b6j contains a similar N-terminal macrocylic HIV-1 protease inhibitor 1b6l contains a similar N-terminal macrocylic HIV-1 protease inhibitor 1b6n contains a similar N-terminal macrocylic HIV-1 protease inhibitor 1b6o contains a similar N-terminal macrocylic HIV-1 protease inhibitor RCSB Y RCSB 1999-10-04 REL REL SO4 SULFATE ION PI9 (10S,13S,1'R)-13-[1'-HYDROXY-2'-(N-P-AMINOBENZENESULFONYL-1''-AMINO-3''-METHYLBUTYL)ETHYL]-8,11-DIOXO-10-ISOPROPYL-2-OXA-9,12-DIAZABICYCLO [13.2.2]NONADECA-15,17,18-TRIENE HOH water SF2 isolate, chemically synthesised protein corresponds to the protease from HIV-1, with 4 mutations per monomer sample SO4 502 2 SO4 SO4 502 A SO4 503 2 SO4 SO4 503 A GLC 201 3 PI9 PI9 201 A SO4 501 2 SO4 SO4 501 B HOH 301 4 HOH HOH 301 A HOH 302 4 HOH HOH 302 A HOH 303 4 HOH HOH 303 A HOH 304 4 HOH HOH 304 A HOH 305 4 HOH HOH 305 A HOH 306 4 HOH HOH 306 A HOH 307 4 HOH HOH 307 A HOH 308 4 HOH HOH 308 A HOH 309 4 HOH HOH 309 A HOH 310 4 HOH HOH 310 A HOH 311 4 HOH HOH 311 A HOH 312 4 HOH HOH 312 A HOH 322 4 HOH HOH 322 A HOH 323 4 HOH HOH 323 A HOH 324 4 HOH HOH 324 A HOH 325 4 HOH HOH 325 A HOH 326 4 HOH HOH 326 A HOH 327 4 HOH HOH 327 A HOH 328 4 HOH HOH 328 A HOH 333 4 HOH HOH 333 A HOH 334 4 HOH HOH 334 A HOH 337 4 HOH HOH 337 A HOH 338 4 HOH HOH 338 A HOH 339 4 HOH HOH 339 A HOH 340 4 HOH HOH 340 A HOH 341 4 HOH HOH 341 A HOH 345 4 HOH HOH 345 A HOH 346 4 HOH HOH 346 A HOH 348 4 HOH HOH 348 A HOH 350 4 HOH HOH 350 A HOH 351 4 HOH HOH 351 A HOH 352 4 HOH HOH 352 A HOH 353 4 HOH HOH 353 A HOH 358 4 HOH HOH 358 A HOH 363 4 HOH HOH 363 A HOH 366 4 HOH HOH 366 A HOH 367 4 HOH HOH 367 A HOH 368 4 HOH HOH 368 A HOH 369 4 HOH HOH 369 A HOH 370 4 HOH HOH 370 A HOH 376 4 HOH HOH 376 A HOH 377 4 HOH HOH 377 A HOH 378 4 HOH HOH 378 A HOH 379 4 HOH HOH 379 A HOH 381 4 HOH HOH 381 A HOH 383 4 HOH HOH 383 A HOH 385 4 HOH HOH 385 A HOH 386 4 HOH HOH 386 A HOH 387 4 HOH HOH 387 A HOH 389 4 HOH HOH 389 A HOH 390 4 HOH HOH 390 A HOH 391 4 HOH HOH 391 A HOH 392 4 HOH HOH 392 A HOH 393 4 HOH HOH 393 A HOH 394 4 HOH HOH 394 A HOH 395 4 HOH HOH 395 A HOH 396 4 HOH HOH 396 A HOH 397 4 HOH HOH 397 A HOH 399 4 HOH HOH 399 A HOH 400 4 HOH HOH 400 A HOH 409 4 HOH HOH 409 A HOH 411 4 HOH HOH 411 A HOH 412 4 HOH HOH 412 A HOH 417 4 HOH HOH 417 A HOH 418 4 HOH HOH 418 A HOH 419 4 HOH HOH 419 A HOH 313 4 HOH HOH 313 B HOH 314 4 HOH HOH 314 B HOH 315 4 HOH HOH 315 B HOH 316 4 HOH HOH 316 B HOH 317 4 HOH HOH 317 B HOH 318 4 HOH HOH 318 B HOH 319 4 HOH HOH 319 B HOH 320 4 HOH HOH 320 B HOH 321 4 HOH HOH 321 B HOH 329 4 HOH HOH 329 B HOH 330 4 HOH HOH 330 B HOH 331 4 HOH HOH 331 B HOH 332 4 HOH HOH 332 B HOH 335 4 HOH HOH 335 B HOH 336 4 HOH HOH 336 B HOH 342 4 HOH HOH 342 B HOH 343 4 HOH HOH 343 B HOH 344 4 HOH HOH 344 B HOH 347 4 HOH HOH 347 B HOH 349 4 HOH HOH 349 B HOH 354 4 HOH HOH 354 B HOH 355 4 HOH HOH 355 B HOH 356 4 HOH HOH 356 B HOH 357 4 HOH HOH 357 B HOH 359 4 HOH HOH 359 B HOH 360 4 HOH HOH 360 B HOH 361 4 HOH HOH 361 B HOH 362 4 HOH HOH 362 B HOH 364 4 HOH HOH 364 B HOH 365 4 HOH HOH 365 B HOH 371 4 HOH HOH 371 B HOH 372 4 HOH HOH 372 B HOH 373 4 HOH HOH 373 B HOH 374 4 HOH HOH 374 B HOH 375 4 HOH HOH 375 B HOH 380 4 HOH HOH 380 B HOH 382 4 HOH HOH 382 B HOH 384 4 HOH HOH 384 B HOH 388 4 HOH HOH 388 B HOH 398 4 HOH HOH 398 B HOH 401 4 HOH HOH 401 B HOH 402 4 HOH HOH 402 B HOH 403 4 HOH HOH 403 B HOH 404 4 HOH HOH 404 B HOH 405 4 HOH HOH 405 B HOH 406 4 HOH HOH 406 B HOH 407 4 HOH HOH 407 B HOH 408 4 HOH HOH 408 B HOH 410 4 HOH HOH 410 B HOH 413 4 HOH HOH 413 B HOH 414 4 HOH HOH 414 B HOH 415 4 HOH HOH 415 B HOH 416 4 HOH HOH 416 B HOH 420 4 HOH HOH 420 B HOH 421 4 HOH HOH 421 B PRO 1 n 1 PRO 1 A GLN 2 n 2 GLN 2 A ILE 3 n 3 ILE 3 A THR 4 n 4 THR 4 A LEU 5 n 5 LEU 5 A TRP 6 n 6 TRP 6 A LYS 7 n 7 LYS 7 A ARG 8 n 8 ARG 8 A PRO 9 n 9 PRO 9 A LEU 10 n 10 LEU 10 A VAL 11 n 11 VAL 11 A THR 12 n 12 THR 12 A ILE 13 n 13 ILE 13 A ARG 14 n 14 ARG 14 A ILE 15 n 15 ILE 15 A GLY 16 n 16 GLY 16 A GLY 17 n 17 GLY 17 A GLN 18 n 18 GLN 18 A LEU 19 n 19 LEU 19 A LYS 20 n 20 LYS 20 A GLU 21 n 21 GLU 21 A ALA 22 n 22 ALA 22 A LEU 23 n 23 LEU 23 A LEU 24 n 24 LEU 24 A ASP 25 n 25 ASP 25 A THR 26 n 26 THR 26 A GLY 27 n 27 GLY 27 A ALA 28 n 28 ALA 28 A ASP 29 n 29 ASP 29 A ASP 30 n 30 ASP 30 A THR 31 n 31 THR 31 A VAL 32 n 32 VAL 32 A ILE 33 n 33 ILE 33 A GLU 34 n 34 GLU 34 A GLU 35 n 35 GLU 35 A MET 36 n 36 MET 36 A ASN 37 n 37 ASN 37 A LEU 38 n 38 LEU 38 A PRO 39 n 39 PRO 39 A GLY 40 n 40 GLY 40 A ALA 41 n 41 LYS 41 A TRP 42 n 42 TRP 42 A ALA 43 n 43 LYS 43 A PRO 44 n 44 PRO 44 A ALA 45 n 45 LYS 45 A MET 46 n 46 MET 46 A ILE 47 n 47 ILE 47 A GLY 48 n 48 GLY 48 A GLY 49 n 49 GLY 49 A ILE 50 n 50 ILE 50 A GLY 51 n 51 GLY 51 A GLY 52 n 52 GLY 52 A PHE 53 n 53 PHE 53 A ILE 54 n 54 ILE 54 A LYS 55 n 55 LYS 55 A VAL 56 n 56 VAL 56 A ARG 57 n 57 ARG 57 A GLN 58 n 58 GLN 58 A TYR 59 n 59 TYR 59 A ASP 60 n 60 ASP 60 A GLN 61 n 61 GLN 61 A ILE 62 n 62 ILE 62 A PRO 63 n 63 PRO 63 A VAL 64 n 64 VAL 64 A GLU 65 n 65 GLU 65 A ILE 66 n 66 ILE 66 A ABA 67 n 67 ABA 67 A GLY 68 n 68 GLY 68 A HIS 69 n 69 HIS 69 A LYS 70 n 70 LYS 70 A ALA 71 n 71 ALA 71 A ILE 72 n 72 ILE 72 A GLY 73 n 73 GLY 73 A THR 74 n 74 THR 74 A VAL 75 n 75 VAL 75 A LEU 76 n 76 LEU 76 A VAL 77 n 77 VAL 77 A GLY 78 n 78 GLY 78 A PRO 79 n 79 PRO 79 A THR 80 n 80 THR 80 A PRO 81 n 81 PRO 81 A VAL 82 n 82 VAL 82 A ASN 83 n 83 ASN 83 A ILE 84 n 84 ILE 84 A ILE 85 n 85 ILE 85 A GLY 86 n 86 GLY 86 A ARG 87 n 87 ARG 87 A ASN 88 n 88 ASN 88 A LEU 89 n 89 LEU 89 A LEU 90 n 90 LEU 90 A THR 91 n 91 THR 91 A GLN 92 n 92 GLN 92 A ILE 93 n 93 ILE 93 A GLY 94 n 94 GLY 94 A ABA 95 n 95 ABA 95 A THR 96 n 96 THR 96 A LEU 97 n 97 LEU 97 A ASN 98 n 98 ASN 98 A PHE 99 n 99 PHE 99 A PRO 1 n 1 PRO 1 B GLN 2 n 2 GLN 2 B ILE 3 n 3 ILE 3 B THR 4 n 4 THR 4 B LEU 5 n 5 LEU 5 B TRP 6 n 6 TRP 6 B LYS 7 n 7 LYS 7 B ARG 8 n 8 ARG 8 B PRO 9 n 9 PRO 9 B LEU 10 n 10 LEU 10 B VAL 11 n 11 VAL 11 B THR 12 n 12 THR 12 B ILE 13 n 13 ILE 13 B ARG 14 n 14 ARG 14 B ILE 15 n 15 ILE 15 B GLY 16 n 16 GLY 16 B GLY 17 n 17 GLY 17 B GLN 18 n 18 GLN 18 B LEU 19 n 19 LEU 19 B LYS 20 n 20 LYS 20 B ALA 21 n 21 GLU 21 B ALA 22 n 22 ALA 22 B LEU 23 n 23 LEU 23 B LEU 24 n 24 LEU 24 B ASP 25 n 25 ASP 25 B THR 26 n 26 THR 26 B GLY 27 n 27 GLY 27 B ALA 28 n 28 ALA 28 B ASP 29 n 29 ASP 29 B ASP 30 n 30 ASP 30 B THR 31 n 31 THR 31 B VAL 32 n 32 VAL 32 B ILE 33 n 33 ILE 33 B GLU 34 n 34 GLU 34 B GLU 35 n 35 GLU 35 B MET 36 n 36 MET 36 B ALA 37 n 37 ASN 37 B LEU 38 n 38 LEU 38 B PRO 39 n 39 PRO 39 B GLY 40 n 40 GLY 40 B ALA 41 n 41 LYS 41 B TRP 42 n 42 TRP 42 B ALA 43 n 43 LYS 43 B PRO 44 n 44 PRO 44 B LYS 45 n 45 LYS 45 B MET 46 n 46 MET 46 B ILE 47 n 47 ILE 47 B GLY 48 n 48 GLY 48 B GLY 49 n 49 GLY 49 B ILE 50 n 50 ILE 50 B GLY 51 n 51 GLY 51 B GLY 52 n 52 GLY 52 B PHE 53 n 53 PHE 53 B ILE 54 n 54 ILE 54 B LYS 55 n 55 LYS 55 B VAL 56 n 56 VAL 56 B ARG 57 n 57 ARG 57 B GLN 58 n 58 GLN 58 B TYR 59 n 59 TYR 59 B ASP 60 n 60 ASP 60 B GLN 61 n 61 GLN 61 B ILE 62 n 62 ILE 62 B PRO 63 n 63 PRO 63 B VAL 64 n 64 VAL 64 B GLU 65 n 65 GLU 65 B ILE 66 n 66 ILE 66 B ABA 67 n 67 ABA 67 B GLY 68 n 68 GLY 68 B HIS 69 n 69 HIS 69 B LYS 70 n 70 LYS 70 B ALA 71 n 71 ALA 71 B ILE 72 n 72 ILE 72 B GLY 73 n 73 GLY 73 B THR 74 n 74 THR 74 B VAL 75 n 75 VAL 75 B LEU 76 n 76 LEU 76 B VAL 77 n 77 VAL 77 B GLY 78 n 78 GLY 78 B PRO 79 n 79 PRO 79 B THR 80 n 80 THR 80 B PRO 81 n 81 PRO 81 B VAL 82 n 82 VAL 82 B ASN 83 n 83 ASN 83 B ILE 84 n 84 ILE 84 B ILE 85 n 85 ILE 85 B GLY 86 n 86 GLY 86 B ARG 87 n 87 ARG 87 B ASN 88 n 88 ASN 88 B LEU 89 n 89 LEU 89 B LEU 90 n 90 LEU 90 B THR 91 n 91 THR 91 B GLN 92 n 92 GLN 92 B ILE 93 n 93 ILE 93 B GLY 94 n 94 GLY 94 B ABA 95 n 95 ABA 95 B THR 96 n 96 THR 96 B LEU 97 n 97 LEU 97 B ASN 98 n 98 ASN 98 B PHE 99 n 99 PHE 99 B author_and_software_defined_assembly PISA 2 dimeric 5450 -58 9000 A ABA 67 ALPHA-AMINOBUTYRIC ACID A ABA 67 ALA A ABA 95 ALPHA-AMINOBUTYRIC ACID A ABA 95 ALA B ABA 67 ALPHA-AMINOBUTYRIC ACID B ABA 67 ALA B ABA 95 ALPHA-AMINOBUTYRIC ACID B ABA 95 ALA 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 A N ILE 3 A N ILE 3 B O LEU 97 B O LEU 97 B N ASN 98 B N ASN 98 A O THR 96 A O THR 96 A O LEU 97 A O LEU 97 B N ILE 3 B N ILE 3 A O ILE 47 A O ILE 47 A N ILE 54 A N ILE 54 A N ILE 66 A N ILE 66 A O HIS 69 A O HIS 69 A O LEU 76 A O LEU 76 A N ILE 33 A N ILE 33 A O VAL 32 A O VAL 32 A N ILE 84 A N ILE 84 A N ILE 85 A N ILE 85 A O LEU 23 A O LEU 23 A O ALA 22 A O ALA 22 A N VAL 11 A N VAL 11 A O ARG 14 A O ARG 14 A N GLU 65 A N GLU 65 B N GLY 49 B N GLY 49 B O GLY 52 B O GLY 52 B N ILE 66 B N ILE 66 B O HIS 69 B O HIS 69 B N LEU 76 B N LEU 76 B O THR 31 B O THR 31 B O VAL 32 B O VAL 32 B N ILE 84 B N ILE 84 B N ILE 85 B N ILE 85 B O LEU 23 B O LEU 23 B O ALA 22 B O ALA 22 B N VAL 11 B N VAL 11 B O ARG 14 B O ARG 14 B N GLU 65 B N GLU 65 1 A CG LYS 41 A CG LYS 41 1 Y 1 A CD LYS 41 A CD LYS 41 1 Y 1 A CE LYS 41 A CE LYS 41 1 Y 1 A NZ LYS 41 A NZ LYS 41 1 Y 1 A CG LYS 43 A CG LYS 43 1 Y 1 A CD LYS 43 A CD LYS 43 1 Y 1 A CE LYS 43 A CE LYS 43 1 Y 1 A NZ LYS 43 A NZ LYS 43 1 Y 1 A CG LYS 45 A CG LYS 45 1 Y 1 A CD LYS 45 A CD LYS 45 1 Y 1 A CE LYS 45 A CE LYS 45 1 Y 1 A NZ LYS 45 A NZ LYS 45 1 Y 1 B CG GLU 21 B CG GLU 21 1 Y 1 B CD GLU 21 B CD GLU 21 1 Y 1 B OE1 GLU 21 B OE1 GLU 21 1 Y 1 B OE2 GLU 21 B OE2 GLU 21 1 Y 1 B CG ASN 37 B CG ASN 37 1 Y 1 B OD1 ASN 37 B OD1 ASN 37 1 Y 1 B ND2 ASN 37 B ND2 ASN 37 1 Y 1 B CG LYS 41 B CG LYS 41 1 Y 1 B CD LYS 41 B CD LYS 41 1 Y 1 B CE LYS 41 B CE LYS 41 1 Y 1 B NZ LYS 41 B NZ LYS 41 1 Y 1 B CG LYS 43 B CG LYS 43 1 Y 1 B CD LYS 43 B CD LYS 43 1 Y 1 B CE LYS 43 B CE LYS 43 1 Y 1 B NZ LYS 43 B NZ LYS 43 1 Y 1 A PRO 79 -68.86 69.07 parhcsdx.pro tophcsdx.pro nal.par Inhibiter1.top toph19.sol so4.inp 19.5 0.00 0.00 0.00 0.00 0.00 0.00 0.2310000 0.005 0.1890000 0.1890000 0.1890000 1.75 8.00 1791 18244 18244 9.8 94.9 RANDOM 10000000.00 0.001 1 RESTRAINED THROUGHOUT 0.0 0.0 Engh & Huber 0.23 0.18 5.00 0.27 0.23 1.75 8.00 121 1721 60 0 1540 0.009 1.5 27.3 1.42 1.43 1.50 2.24 2.00 2.51 2.00 4.17 2.50 0.3200000 0.020 0.2810000 1.86 251 2459 6 9.3 86.1 10.2 1.75 50.0 1D4L 62454 59019 0.0 1.0 0.0830000 1 9.5 3.38 94.5 0.3020000 1.75 1.83 1621 3.35 84.6 model building X-PLOR refinement X-PLOR 3.851 data reduction DENZO data scaling SCALEPACK phasing X-PLOR HIV-1 PROTEASE COMPLEXED WITH A MACROCYCLIC PEPTIDOMIMETIC INHIBITOR 1 N N 1 N N 2 N N 2 N N 3 N N 2 N N 4 N N 4 N N A GLY 86 A GLY 86 HELX_P A THR 91 A THR 91 1 1 6 B GLY 86 B GLY 86 HELX_P B THR 91 B THR 91 1 2 6 covale 1.331 both A ILE 66 A C ILE 66 1_555 A ABA 67 A N ABA 67 1_555 covale 1.326 both A ABA 67 A C ABA 67 1_555 A GLY 68 A N GLY 68 1_555 covale 1.331 both A GLY 94 A C GLY 94 1_555 A ABA 95 A N ABA 95 1_555 covale 1.334 both A ABA 95 A C ABA 95 1_555 A THR 96 A N THR 96 1_555 covale 1.332 both B ILE 66 B C ILE 66 1_555 B ABA 67 B N ABA 67 1_555 covale 1.334 both B ABA 67 B C ABA 67 1_555 B GLY 68 B N GLY 68 1_555 covale 1.334 both B GLY 94 B C GLY 94 1_555 B ABA 95 B N ABA 95 1_555 covale 1.336 both B ABA 95 B C ABA 95 1_555 B THR 96 B N THR 96 1_555 HYDROLASE HIV, PROTEASE, INHIBITOR, ANTIVIRAL, HYDROLASE POL_HV1A2 UNP 1 P03369 57 155 1D4L 1 99 P03369 A 1 1 99 57 155 1D4L 1 99 P03369 B 1 1 99 1 GLN engineered mutation LYS 7 1D4L A P03369 UNP 63 7 1 LEU engineered mutation ILE 33 1D4L A P03369 UNP 89 33 1 CYS engineered mutation ABA 67 1D4L A P03369 UNP 123 67 1 CYS engineered mutation ABA 95 1D4L A P03369 UNP 151 95 2 GLN engineered mutation LYS 7 1D4L B P03369 UNP 63 7 2 LEU engineered mutation ILE 33 1D4L B P03369 UNP 89 33 2 CYS engineered mutation ABA 67 1D4L B P03369 UNP 123 67 2 CYS engineered mutation ABA 95 1D4L B P03369 UNP 151 95 4 8 8 anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel parallel anti-parallel parallel anti-parallel anti-parallel anti-parallel anti-parallel parallel anti-parallel parallel anti-parallel anti-parallel A GLN 2 A GLN 2 A THR 4 A THR 4 B THR 96 B THR 96 B ASN 98 B ASN 98 A THR 96 A THR 96 A ASN 98 A ASN 98 B GLN 2 B GLN 2 B THR 4 B THR 4 A LYS 43 A LYS 43 A GLY 48 A GLY 48 A PHE 53 A PHE 53 A ILE 66 A ILE 66 A HIS 69 A HIS 69 A VAL 77 A VAL 77 A VAL 32 A VAL 32 A ILE 33 A ILE 33 A ILE 84 A ILE 84 A ILE 85 A ILE 85 A GLN 18 A GLN 18 A LEU 24 A LEU 24 A LEU 10 A LEU 10 A ILE 15 A ILE 15 A PHE 53 A PHE 53 A ILE 66 A ILE 66 B LYS 43 B LYS 43 B GLY 49 B GLY 49 B GLY 52 B GLY 52 B ILE 66 B ILE 66 B HIS 69 B HIS 69 B GLY 78 B GLY 78 B THR 31 B THR 31 B GLU 34 B GLU 34 B ILE 84 B ILE 84 B ILE 85 B ILE 85 B GLN 18 B GLN 18 B LEU 24 B LEU 24 B LEU 10 B LEU 10 B ILE 15 B ILE 15 B GLY 52 B GLY 52 B ILE 66 B ILE 66 BINDING SITE FOR RESIDUE SO4 B 501 B SO4 501 Software 6 BINDING SITE FOR RESIDUE SO4 A 502 A SO4 502 Software 5 BINDING SITE FOR RESIDUE SO4 A 503 A SO4 503 Software 4 BINDING SITE FOR RESIDUE PI9 A 201 A PI9 201 Software 22 A GLY 68 A GLY 68 6 3_545 A HIS 69 A HIS 69 6 3_545 A LYS 70 A LYS 70 6 3_545 A HOH 353 G HOH 6 3_545 B PRO 1 B PRO 1 6 2_554 B LYS 55 B LYS 55 6 1_555 A PRO 1 A PRO 1 5 1_555 A ABA 67 A ABA 67 5 1_555 A HIS 69 A HIS 69 5 1_555 A HOH 363 G HOH 5 1_555 A HOH 417 G HOH 5 1_555 A ARG 14 A ARG 14 4 1_555 B ARG 14 B ARG 14 4 1_455 B GLY 16 B GLY 16 4 1_455 B GLY 17 B GLY 17 4 1_455 A ASP 25 A ASP 25 22 1_555 A GLY 27 A GLY 27 22 1_555 A ALA 28 A ALA 28 22 1_555 A ASP 29 A ASP 29 22 1_555 A GLY 48 A GLY 48 22 1_555 A GLY 49 A GLY 49 22 1_555 A ILE 50 A ILE 50 22 1_555 A PRO 81 A PRO 81 22 1_555 A VAL 82 A VAL 82 22 1_555 A ILE 84 A ILE 84 22 1_555 A HOH 301 G HOH 22 1_555 B ARG 8 B ARG 8 22 1_555 B ASP 25 B ASP 25 22 1_555 B GLY 27 B GLY 27 22 1_555 B ALA 28 B ALA 28 22 1_555 B ASP 30 B ASP 30 22 1_555 B VAL 32 B VAL 32 22 1_555 B GLY 48 B GLY 48 22 1_555 B GLY 49 B GLY 49 22 1_555 B ILE 50 B ILE 50 22 1_555 B VAL 82 B VAL 82 22 1_555 B ILE 84 B ILE 84 22 1_555 19 P 21 21 21